Burning Rock Biotech (BNR) Consolidated Net Income (2019 - 2026)

Burning Rock Biotech (BNR) has reported Consolidated Net Income for 8 consecutive years, with -$2.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Consolidated Net Income fell 36.76% year-over-year to -$2.5 million; the TTM figure through Mar 2026 stood at -$8.0 million (up 74.64% YoY), while the FY2025 annual figure was -$7.9 million, up 83.33% from the prior year.
• Consolidated Net Income came in at -$2.5 million for Q1 2026 at Burning Rock Biotech, down from -$1.9 million in the prior quarter.
• The five-year high for Consolidated Net Income was -$1.3 million in Q2 2025, with the low at -$41.2 million in Q1 2022.
• Average Consolidated Net Income over 5 years is -$17.2 million, with a median of -$16.8 million recorded in 2024.
• Across the five-year window, Consolidated Net Income tumbled 57.42% in 2022 and surged 91.43% in 2025, its largest moves.
• Year by year, Consolidated Net Income stood at -$30.8 million in 2022, then gained by 26.79% to -$22.5 million in 2023, then jumped by 57.06% to -$9.7 million in 2024, then soared by 79.87% to -$1.9 million in 2025, then fell by 25.99% to -$2.5 million in 2026.
• According to Business Quant data, Consolidated Net Income over the past three periods registered -$2.5 million, -$1.9 million, and -$2.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.